Insulin-like Growth Factor-binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-independent Radiation-induced Apoptosis in Human Breast Cancer Cells
Open Access
- 1 December 2000
- journal article
- Published by Elsevier BV
- Vol. 275 (50), 39174-39181
- https://doi.org/10.1074/jbc.m908888199
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- The IGF axis and programmed cell deathImmunology & Cell Biology, 1999
- Development of Resistance to Insulin-like Growth Factor Binding Protein-3 in Transfected T47D Breast Cancer CellsBiochemical and Biophysical Research Communications, 1998
- Insulin-like Growth Factor Binding Protein-3 Induces Apoptosis in MCF7 Breast Cancer CellsBiochemical and Biophysical Research Communications, 1997
- Overexpression of the Bcl-2 Protein Increases the Half-life of p21BaxPublished by Elsevier BV ,1995
- Insulin‐like growth factor‐binding protein enhancement of insulin‐like growth factor‐i (IGF‐I)–mediated DNA synthesis and IGF‐I binding in a human breast carcinoma cell lineJournal of Cellular Physiology, 1994
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Insulin-like growth factor-I (IGF-I) and transforming growth factor- beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanismsEndocrinology, 1992
- The insulin-like growth factor binding proteins (IGFBPs) in human breast cancerBreast Cancer Research and Treatment, 1992
- Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblastsBiochemical and Biophysical Research Communications, 1988